Rejected at 12:55 p.m. Jun, 30, 2026 ] by Ahmed7
Author: km1_007
Related Note: 1474580948335
Rationale for change

Shows omalizumab MoA
Source: Other - Source attached below image

Rejection reason

incorrect photo credit source and format

Please resubmit with acceptable image formatting guidelines. Please review suggestion guidelines, specifically rule #3: https://community.ankihub.net/t/anking-step-deck-submission-guidelines/166504

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Empty field
Additional Resources
One by one
Empty field
#AK_Step2_v12::#SketchyPeds::05_Respiratory_&_Pulmonology::02_Lower_Airway_Disease::03_Asthma_in_Children #AK_Step1_v12::#Physeo::09_Pharm::08_Respiratory::07_Alternative_Asthma_Treatment #AK_Step2_v12::#Subjects::Pulmonology::05_Lungs::Obstructive_Lung_Disease::Asthma #AK_Step1_v12::#Physeo::09_Pharm::08_Respiratory::06_Asthma_Treatment #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Other::AnKing_Image::AhmedA::IgE_Dependent_Mast_Cells_Activation #AK_Step1_v12::#Pixorize::03_Pharmacology::20_Respiratory_Pharm::08_Omalizumab #AK_Step1_v12::#UWorld::Step::2128 #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::^Systems::Respiratory::Pharmacology #AK_Step1_v12::#Bootcamp::Pulmonology::05_Obstructive_Lung_Disease::03_Asthma_Treatments #AK_Step2_v12::#Bootcamp::Medicine::02_Pulmonary_and_Critical_Care::01_Obstructive_Lung_Diseases::04_Chronic_Asthma_Management #AK_Step2_v12::#Subjects::Pulmonology::05_Lungs::Obstructive_Lung_Disease::Asthma::Management_Redo #PANCE::PULM::obstructive_pulmonary_diseases #AK_Step1_v12::#FirstAid::16_Respiratory::05_Pharm::05_Asthma_drugs #AK_Step1_v12::#SketchyPharm::04_Smooth_Muscle::02_Allergy_&_Pulmonary::02_Asthma_therapy #AK_Step1_v12::#FirstAid::16_Respiratory::05_Pharm::05_Asthma_drugs::05_Anti-IgE_monoclonal_therapy #AK_Step2_v12::#SketchyIM::03_Pulmonology::02_Obstructive_Pulmonary_Diseases::02_Chronic_Asthma_Management #AK_Step1_v12::#AMBOSS::uOap8k #AK_Step2_v12::!Shelf::FM #AK_Step1_v12::#B&B::20_Pulm::02_Obstructive_and_Restrictive_Diseases::05_Treatment_of_COPD_and_Asthma #AK_Step1_v12::#OME::PreClinical::General_Physiology::Smooth_Muscle #AK_Other::AnKing_Image::!Subjects::Immunology_&_Pathology::IgE_Dependent_Mast_Cells_Activation #AK_Step2_v12::#B&B::14_Pulmonary_Critical_Care::01_Pulmonary_Disease::02_Asthma #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies::*Omalizumab #AK_Step2_v12::#Resources_by_rotation::FM::casefiles::wheezing&asthma #AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::#B&B::20_Pulm::02_Obstructive_and_Restrictive_Diseases::05_Treatment_of_COPD_and_Asthma::Extra #AK_Step1_v12::#UWorld::COMLEX::25237 #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#Physeo::^physeo_image_update